Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R&D OUTSOURCING TO INCREASE 30% YEARLY FOR FIVE TO 10 YEARS, CORNING VP SAYS; SPONSOR/CRO/SITE COOPERATION MUST GET BETTER, ACIL CONFERENCE HEARS

Executive Summary

Outsourcing in drug development will increase about 30% from year to year, "a tremendous increase" over the next five to 10 years, Corning-Besselaar VP-Business Development Jeffrey McMullen told the ACIL Second Annual Life Sciences Forum Jan. 31 in Arlington, Va.
UsernamePublicRestriction

Register

PS027606

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel